DeNovX has received the exciting news that its company-owned patents for improving crystallization using engineered nucleation features have been granted by the European and Canadian patent offices. These patents add to the already issued patents in the US and Japan (below), signalling broad coverage in those jurisdictions in which crystallization is an important process in the pharmaceutical, food, cosmetic, agricultural, fine chemical, and bioengineering fields that stand to benefit from these crystal nucleation technologies